飞金止痛胶囊联合甲氨蝶呤和雷公藤多苷治疗类风湿关节炎的临床观察
x
请在关注微信后,向客服人员索取文件
篇名: | 飞金止痛胶囊联合甲氨蝶呤和雷公藤多苷治疗类风湿关节炎的临床观察 |
TITLE: | |
摘要: | 目的:探讨飞金止痛胶囊联合甲氨蝶呤和雷公藤多苷治疗类风湿关节炎的临床疗效及安全性。方法:70例类风湿关节炎患者按随机数字表法分为对照组(34例)与观察组(36例)。对照组患者给予注射用甲氨蝶呤静脉滴注,每次10 mg,每周1次;同时给予雷公藤多苷片口服,每次10 mg,bid。观察组患者在对照组治疗基础上给予飞金止痛胶囊口服,每次3粒,bid。两组疗程均为6个月。观察两组患者的临床疗效,治疗前后症状、体征、红细胞沉降率(ESR)和类风湿因子(RF)、C反应蛋白(CRP)、白细胞介素(IL)1、IL-6、IL-8、肿瘤坏死因子(TNF)-α水平,并记录不良反应发生情况。结果 :观察组患者的有效率为85.71%,显著高于对照组的70.59%,差异有统计学意义(P<0.05)。治疗后,两组患者的晨僵时间、关节疼痛指数、关节肿胀度指数、关节压痛指数、ESR、RF、CRP、IL-1、IL-6、IL-8、TNF-α均显著低于治疗前,且观察组均显著低于对照组,差异均有统计学意义(P<0.05或P<0.01)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论:飞金止痛胶囊联合甲氨蝶呤和雷公藤多苷治疗类风湿关节炎的疗效和安全性均好,可降低炎性指标水平,改善患者的症状、体征。 |
ABSTRACT: | OBJECTIVE: To observe the clinical efficacy and safety of Feijin zhitong capsule combined with methotrexate and tripterygium glycosides in the treatment of rheumatoid arthritis. METHODS: 70 patients with rheumatoid arthritis were randomly divided into control group (34 cases) and observation group (36 cases). Control group received Methotrexate for injection by intravenous infusion, 10 mg every times, once a week; and also Tripterygium glycosides tablet, 10 mg every times, bid, po. Observation group additionally received Feijin zhitong capsule, 3 capsules every times, bid, po. The treatment course for both groups was 6 months. The clinical efficacy, symptoms and signs, erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), C-reactive protein (CRP), interleukin (IL)-1, IL-6, IL-8 and TNF-α levels before and after treatment in 2 groups were observed, and the incidence of adverse reactions was recorded. RESULTS: The effective rate in observation group was 85.71%, which was significantly higher than control group (70.59%), the difference was statistically significant (P<0.05). After treatment, duration of morning stiffness, joint pain index, joint swelling index, joint tenderness index, ESR, RF, CRP, IL-1, IL-6, IL-8 and TNF-α in 2 groups were significantly lower than before, and observation group was lower than control group, the differences were statistically significant (P<0.05 or P<0.01). And there was no significant difference in the adverse reactions in 2 groups (P>0.05). CONCLUSIONS: Feijin zhitong capsule combined with methotrexate and tripterygium glycosides has good efficacy and safety in the treatment of rheumatoid arthritis, it can reduce the inflammatory index level, improve symptom and sign. |
期刊: | 2016年第27卷第23期 |
作者: | 杨通宇,胡鲲,刘照时,李溥,陆耀宇,甘龙飞,胡建山 |
AUTHORS: | YANG Tongyu,HU Kun,LIU Zhaoshi,LI Pu,LU Yaoyu,GAN Longfei,HU Jianshan |
关键字: | 飞金止痛胶囊;甲氨蝶呤;雷公藤多苷;类风湿关节炎;疗效;安全性 |
KEYWORDS: | Feijin zhitong capsule; Methotrexate; Tripterygium glycosides; Rheumatoid arthritis; Efficacy; Safety |
阅读数: | 316 次 |
本月下载数: | 1 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!